TP53 and ovarian cancer: Recently, however, immunohistochemical analysis of CRYAB and p53 has revealed that both proteins are highly expressed in ovarian cancer specimens and their co-expression can serve as independent prognostic factor of disease-free survival (DFS) and overall survival (OS) [190].